Michael R. Michaelides

2.3k total citations
15 papers, 751 citations indexed

About

Michael R. Michaelides is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Michael R. Michaelides has authored 15 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Michael R. Michaelides's work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (4 papers). Michael R. Michaelides is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers) and Peptidase Inhibition and Analysis (4 papers). Michael R. Michaelides collaborates with scholars based in United States, United Kingdom and Canada. Michael R. Michaelides's co-authors include Steven K. Davidsen, Patrick A. Marcotte, Lori J. Pease, Keith B. Glaser, Junling Li, Michael L. Curtin, Robin R. Frey, Robert B. Garland, Gary G. Chiang and Ramzi F. Sweis and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Michael R. Michaelides

15 papers receiving 723 citations

Peers

Michael R. Michaelides

ONCOL

PHARM

Peter Chua Canada

Carol K. Wada United States

Silvana Leit United States

Ferdinando Maria Milazzo Italy

Shaughnessy Robinson United States

Raj Betageri United States

David P. Kay United States

Shaun Fillery United Kingdom

Peter F. Bousquet United States

Kevin Blades United Kingdom

Peter Chua Canada

Michael R. Michaelides

443 ×0.8

323 ×1.1

111 ×0.8

ONCOL

49 ×1.1

29 ×1.0

PHARM

Citations per year, relative to Michael R. Michaelides Michael R. Michaelides (= 1×) peers Peter Chua

Countries citing papers authored by Michael R. Michaelides

Since Specialization

Citations

This map shows the geographic impact of Michael R. Michaelides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Michaelides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Michaelides more than expected).

Fields of papers citing papers by Michael R. Michaelides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Michaelides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Michaelides. The network helps show where Michael R. Michaelides may publish in the future.

Co-authorship network of co-authors of Michael R. Michaelides

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Michaelides. A scholar is included among the top collaborators of Michael R. Michaelides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Michaelides. Michael R. Michaelides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sorensen, Bryan K., Roberto M. Risi, Michael L. Curtin, et al.. (2023). Enabling, Decagram-Scale Synthesis of Macrocyclic MCL-1 Inhibitor ABBV-467. The Journal of Organic Chemistry. 88(22). 15562–15568. 3 indexed citations

Ji, Zhiqin, Richard F. Clark, Vikram Bhat, et al.. (2021). Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases. Bioorganic & Medicinal Chemistry Letters. 39. 127854–127854. 16 indexed citations

Mastracchio, Anthony, Chunqiu Lai, Enrico L. DiGiammarino, et al.. (2021). Discovery of a Potent and Selective Covalent p300/CBP Inhibitor. ACS Medicinal Chemistry Letters. 12(5). 726–731. 15 indexed citations

Pappano, William N., Jun Guo, Yupeng He, et al.. (2015). The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia. PLoS ONE. 10(7). e0131716–e0131716. 69 indexed citations

Sweis, Ramzi F., Marina Pliushchev, Peter J. Brown, et al.. (2014). Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a. ACS Medicinal Chemistry Letters. 5(2). 205–209. 142 indexed citations

Ji, Zhiqin, Asma A. Ahmed, Daniel H. Albert, et al.. (2006). Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 16(16). 4326–4330. 17 indexed citations

Dai, Yujia, Yan Guo, Jun Guo, et al.. (2003). Indole amide hydroxamic acids as potent inhibitors of histone deacetylases. Bioorganic & Medicinal Chemistry Letters. 13(11). 1897–1901. 34 indexed citations

Vasudevan, Anil, Zhiqin Ji, Robin R. Frey, et al.. (2003). Heterocyclic ketones as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 13(22). 3909–3913. 33 indexed citations

Wada, Carol K., Robin R. Frey, Zhiqin Ji, et al.. (2003). α-Keto amides as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 13(19). 3331–3335. 67 indexed citations

10.

Dai, Yujia, Yan Guo, Michael L. Curtin, et al.. (2003). A novel series of histone deacetylase inhibitors incorporating hetero aromatic ring systems as connection units. Bioorganic & Medicinal Chemistry Letters. 13(21). 3817–3820. 33 indexed citations

11.

Curtin, Michael L., Robert B. Garland, H. Robin Heyman, et al.. (2002). Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC). Bioorganic & Medicinal Chemistry Letters. 12(20). 2919–2923. 97 indexed citations

12.

Frey, Robin R., Carol K. Wada, Robert B. Garland, et al.. (2002). Trifluoromethyl ketones as inhibitors of histone deacetylase. Bioorganic & Medicinal Chemistry Letters. 12(23). 3443–3447. 116 indexed citations

13.

Hajduk, Philip J., Suzanne B. Shuker, David G. Nettesheim, et al.. (2002). NMR-Based Modification of Matrix Metalloproteinase Inhibitors with Improved Bioavailability. Journal of Medicinal Chemistry. 45(26). 5628–5639. 49 indexed citations

14.

Holms, James H., Patrick A. Marcotte, Junling Li, et al.. (2001). Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzyme. Bioorganic & Medicinal Chemistry Letters. 11(22). 2907–2910. 41 indexed citations

15.

Roush, William & Michael R. Michaelides. (1986). Studies on the total synthesis of sesbanimide: A highly diastereoselective synthesis of the ab ring system. Tetrahedron Letters. 27(29). 3353–3356. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact